ARUP's Laboratory Test Directory

Hypochondroplasia (FGFR3) 1 Mutation : 0051367
[ image for: Additional Technical Information]
Additional Technical Information
  


Mnemonic: HYPOCH

Ordering Recommendation: Diagnostic testing for hypochondroplasia.
Methodology: Polymerase Chain Reaction/Fluorescence Monitoring
Performed: Mon, Thu
Reported: Within 7 days
Specimen Required: Collect: Lavender (EDTA), pink (K2EDTA), or yellow (ACD Solution A or B).

Specimen Preparation: Transport 3 mL whole blood. (Min: 1 mL)

Storage/Transport Temperature: Refrigerated.

Stability (collection to initiation of testing): Ambient: 72 hours; Refrigerated: 1 week; Frozen: Unacceptable

Reference Interval:
By report
Interpretive Data: Background Information for Hypochondroplasia (FGFR3) 1 Mutation:
Characteristics:
Short stature, stocky build, large head, shortening of the proximal or middle segments of the extremities, short broad hands and feet, limitation of elbow extension, and mild joint laxity. Phenotype not evident in infancy, becomes apparent in childhood.
Incidence:
1:15,000-40,000
Inheritance:
Autosomal dominant; usually arising from a de novo mutation.
Cause:
70 percent of cases result from an A or G nucleotide substitution for C at 1620 in the FGFR3 gene.
Methods:
PCR and fluorescent resonance energy transfer.
Limitations:
Mutations in FGFR3 and other than c.1620C>A/G will not be detected.
Analytic Sensitivity and Specificity:
99 percent
Clinical Sensitivity:
70 percent

This test is performed pursuant to an agreement with Roche Molecular Systems, Inc.



Counseling and informed consent are recommended for genetic testing. Consent forms are available online at www.aruplab.com.

See Compliance Statement C: www.aruplab.com/CS
CPT Code(s): 81401